by In2Pharma | Sep 25, 2019 | News
Belgium On 20 May 2019, the law changing provisions has been published in the Belgian Official Gazette. The new law changes a number of aspects of the function and financing of the Federal Agency for Medicines and Health Products (FAMHP). The financing law of...
by In2Pharma | Sep 24, 2019 | News
Belgium There are new Belgian rules from 1 May 2019 for the harmonisation of SPC, labelling and patient leaflet. Marketing authorisation holders and applicants can find the new rules for harmonisation of SPC’s, labelling and patient information leaflets on the...
by In2Pharma | Jul 30, 2019 | News
Belgium The new Belgian Company Code, which concerns companies and associations, and which came into force on 1 May 2019, refers to only 4 corporate forms. This will have implications for some authorisations and registrations in the sense that holders thereof...
by In2Pharma | Jun 7, 2019 | News
Belgium The FAMHP has published a news item on their website concerning payments to the FAMHP. From now on, the FAMHP will send out invoices with structured message for most of its services. As a result, companies will no longer need to make advance payments (via an...
by In2Pharma | Jun 7, 2019 | News
Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...
